Yumei Li

664 total citations
33 papers, 528 citations indexed

About

Yumei Li is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yumei Li has authored 33 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Yumei Li's work include Immune Cell Function and Interaction (7 papers), MicroRNA in disease regulation (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Yumei Li is often cited by papers focused on Immune Cell Function and Interaction (7 papers), MicroRNA in disease regulation (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Yumei Li collaborates with scholars based in China, France and United States. Yumei Li's co-authors include Qiong Wu, Yan Yang, Rui Wang, Zishu Wang, Shukui Qin, Yang Liu, Fang Su, Hao Bo, Jing Liu and Jin Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Engineering Journal and Advanced Science.

In The Last Decade

Yumei Li

31 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yumei Li China 14 295 228 131 88 66 33 528
Bowen Li China 13 264 0.9× 185 0.8× 135 1.0× 55 0.6× 67 1.0× 41 500
Houyu Ju China 14 214 0.7× 146 0.6× 162 1.2× 69 0.8× 57 0.9× 28 415
Mao Li China 15 291 1.0× 267 1.2× 163 1.2× 77 0.9× 72 1.1× 37 620
Wenhao Ren China 15 511 1.7× 367 1.6× 111 0.8× 53 0.6× 118 1.8× 56 708
Jiao He China 10 221 0.7× 112 0.5× 133 1.0× 117 1.3× 29 0.4× 19 494
Yuanhang Liu United States 12 281 1.0× 145 0.6× 217 1.7× 178 2.0× 65 1.0× 49 643
Ye Kang China 16 296 1.0× 305 1.3× 118 0.9× 53 0.6× 32 0.5× 32 608
Yongzhong Luo China 11 171 0.6× 91 0.4× 95 0.7× 77 0.9× 65 1.0× 40 411
YiJiang Song China 12 151 0.5× 105 0.5× 96 0.7× 116 1.3× 57 0.9× 22 481
Yuanbo Xue China 12 247 0.8× 122 0.5× 248 1.9× 180 2.0× 59 0.9× 14 488

Countries citing papers authored by Yumei Li

Since Specialization
Citations

This map shows the geographic impact of Yumei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumei Li more than expected).

Fields of papers citing papers by Yumei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumei Li. The network helps show where Yumei Li may publish in the future.

Co-authorship network of co-authors of Yumei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yumei Li. A scholar is included among the top collaborators of Yumei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumei Li. Yumei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xi, Fei Song, Peng Xiao, et al.. (2025). Spermine accumulation via spermine synthase promotes tumor cell proliferation in head and neck squamous cell carcinoma. BMC Cancer. 25(1). 402–402. 1 indexed citations
2.
Zhao, Qing‐Li, Ryohei Ogawa, Tatsuji Mizukami, et al.. (2025). Exploring the therapeutic potential of 4,4′-dimethoxychalcone: Inducing apoptosis in cancer cells via ER stress and autophagy disruption. Cellular Signalling. 132. 111854–111854. 1 indexed citations
4.
Lü, Sijia, Yangyun Zou, Cheng Wan, et al.. (2025). Establishment and application of an RNA-seq-based predictive model for the hourly precision window of implantation (WOI) in patients with recurrent implantation failure. Journal of Assisted Reproduction and Genetics. 42(6). 2067–2082. 1 indexed citations
5.
Li, Yong-Dong, et al.. (2024). Current Status and Influencing Factors of Readiness for Hospital Discharge of Lung Cancer Patients Receiving ERAS-Guided Postoperative Management. Cancer Control. 31. 2925705059–2925705059. 1 indexed citations
6.
Wang, Biyao, Bing Xie, Lina Sui, et al.. (2024). Interferon regulatory factor 7 alleviates the experimental colitis through enhancing IL-28A-mediated intestinal epithelial integrity. Journal of Translational Medicine. 22(1). 905–905. 1 indexed citations
9.
Zhang, Shuai, Liwei Zhao, Mengfei Guo, et al.. (2023). Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses. Journal for ImmunoTherapy of Cancer. 11(7). e006785–e006785. 11 indexed citations
10.
Guo, Hui, Cheng Zhang, Xiaotong Tang, et al.. (2022). HHLA2 Activates the JAK/STAT Signaling Pathway by Binding to TMIGD2 in Hepatocellular Carcinoma Cells. Inflammation. 45(4). 1585–1599. 12 indexed citations
11.
Li, Yumei, et al.. (2022). A novel multifunctional anti-PD-L1-CD16a-IL15 induces potent cancer cell killing in PD-L1-positive tumour cells. Translational Oncology. 21. 101424–101424. 9 indexed citations
12.
Wang, Rui, Hui Guo, Xiaotong Tang, et al.. (2021). Interferon Gamma-Induced Interferon Regulatory Factor 1 Activates Transcription of HHLA2 and Induces Immune Escape of Hepatocellular Carcinoma Cells. Inflammation. 45(1). 308–330. 25 indexed citations
13.
Liu, Jing, et al.. (2018). HER2 positive bilateral metachronous primary breast carcinoma: A case report. Cancer Biology & Therapy. 19(5). 349–354. 1 indexed citations
14.
Yang, Yan, Shukui Qin, Jian Zhu, et al.. (2017). A Rare STRN-ALK Fusion in Lung Adenocarcinoma Identified Using Next-Generation Sequencing–Based Circulating Tumor DNA Profiling Exhibits Excellent Response to Crizotinib. SHILAP Revista de lepidopterología. 1(1). 111–116. 25 indexed citations
15.
Ma, Lizhen, Dandan Li, Chunxiu Yuan, et al.. (2017). SjCRT, a recombinant Schistosoma japonicum calreticulin, induces maturation of dendritic cells and a Th1-polarized immune response in mice. Parasites & Vectors. 10(1). 570–570. 12 indexed citations
16.
Wu, Qiong, et al.. (2016). Programmed cell death 1 correlates with the occurrence and development of MG63 osteosarcoma. Oncology Letters. 12(6). 5199–5204. 4 indexed citations
17.
Liu, Yang, Yumei Li, Rui Wang, et al.. (2016). MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells. Journal of Experimental & Clinical Cancer Research. 35(1). 19–19. 75 indexed citations
18.
Li, Yumei, et al.. (2016). Cinepazide Maleate Improves Cognitive Function and Protects Hippocampal Neurons in Diabetic Rats with Chronic Cerebral Hypoperfusion. Biological and Pharmaceutical Bulletin. 40(3). 249–255. 14 indexed citations
19.
Yang, Yan, Yumei Li, Rui Wang, et al.. (2016). Role of IL-33 expression in oncogenesis and development of human hepatocellular carcinoma. Oncology Letters. 12(1). 429–436. 15 indexed citations
20.
Wang, Xi, Guanzhen Yu, Jiejun Wang, et al.. (2013). Expression of group IIA phospholipase A2 is an independent predictor of favorable outcome for patients with gastric cancer. Human Pathology. 44(10). 2020–2027. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026